Hideaki Imamura

599 total citations
37 papers, 440 citations indexed

About

Hideaki Imamura is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Hideaki Imamura has authored 37 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Organic Chemistry. Recurrent topics in Hideaki Imamura's work include Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Enzyme Catalysis and Immobilization (6 papers). Hideaki Imamura is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Enzyme Catalysis and Immobilization (6 papers). Hideaki Imamura collaborates with scholars based in Japan, Pakistan and United States. Hideaki Imamura's co-authors include Hajime Morishima, Terutaka Hashizume, Koji Yamada, Rie Nagano, Jinsaku Sakakibara, Naoki Yamada, Tsumoru Morimoto, Aya Shimizu, Hiroki Sato and Nobutoshi Murakami and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Hideaki Imamura

36 papers receiving 419 citations

Peers

Hideaki Imamura

PHARM

Takatoshi Nagate Japan

Sheng Tang China

William F. Demyan United States

Robert E. Lee Trout United States

Samar H. Abbas Egypt

Zongqiang Wang China

Ronald M. Stroshane United States

Monika I. Konaklieva United States

Kongkai Zhu China

Takatoshi Nagate Japan

Hideaki Imamura

144 ×1.0

305 ×2.2

103 ×0.9

PHARM

40 ×0.4

46 ×0.9

Citations per year, relative to Hideaki Imamura Hideaki Imamura (= 1×) peers Takatoshi Nagate

Countries citing papers authored by Hideaki Imamura

Since Specialization

Citations

This map shows the geographic impact of Hideaki Imamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Imamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Imamura more than expected).

Fields of papers citing papers by Hideaki Imamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Imamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Imamura. The network helps show where Hideaki Imamura may publish in the future.

Co-authorship network of co-authors of Hideaki Imamura

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Imamura. A scholar is included among the top collaborators of Hideaki Imamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Imamura. Hideaki Imamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miura, Kenichiro, Yasuyuki Sato, Naoto Kaneko, et al.. (2020). Individualized concept for the treatment of autosomal recessive polycystic kidney disease with end‐stage renal disease. Pediatric Transplantation. 24(3). e13690–e13690. 1 indexed citations

Imamura, Hideaki, Etsuko Tanaka, Satoshi Hisano, et al.. (2015). Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B. Nephrology Dialysis Transplantation. 30(5). 862–864. 20 indexed citations

Imamura, Hideaki, Koji Muroya, Etsuko Tanaka, et al.. (2015). Sporadic paraganglioma caused by de novo SDHB mutations in a 6-year-old girl. European Journal of Pediatrics. 175(1). 137–141. 10 indexed citations

Tanaka, Etsuko, et al.. (2014). Nephrotic syndrome complicated by idiopathic central diabetes insipidus. Pediatric Nephrology. 29(5). 927–930. 1 indexed citations

Tanaka, Etsuko, et al.. (2011). ANCA-negative microscopic polyangiitis associated with streptococcal infection in a 12-year-old boy. Japanese journal of pediatric nephrology. 24(1). 96–102. 2 indexed citations

Kawachi, Shoji, Takeji Matsushita, Takeyuki Sato, et al.. (2011). Multicenter prospective evaluation of a novel rapid immunochromatographic diagnostic kit specifically detecting influenza A H1N1 2009 virus. Journal of Clinical Virology. 51(1). 68–72. 9 indexed citations

Sakoh, Hiroki, Yuichi Sugimoto, Hideaki Imamura, et al.. (2003). Novel galbonolide derivatives as IPC synthase inhibitors: design, synthesis and in vitro antifungal activities. Bioorganic & Medicinal Chemistry Letters. 14(1). 143–145. 11 indexed citations

Sato, Hiroki, Hiroki Sakoh, Takashi Hashihayata, et al.. (2002). Structure–Activity Relationships of 1β-Methyl-2-(5-phenylpyrrolidin-3-ylthio)carbapenems. Bioorganic & Medicinal Chemistry. 10(5). 1595–1610. 8 indexed citations

Kinoshita, Akihiro, et al.. (2001). Influence of Different Nutrient Conditions on Ovarian Follicular Dynamics in Dairy Cows. Nihon Chikusan Gakkaiho. 72(7). 20–27. 1 indexed citations

10.

Hashihayata, Takashi, Hiroki Sakoh, Yasuhiro Gotô, et al.. (2001). Diastereoselective Synthesis of (2R,4R)-2-Aryl-4-hydroxypyrrolidine: Preparation of the Side Chain of Novel Carbapenem.. Chemical and Pharmaceutical Bulletin. 49(11). 1500–1502. 2 indexed citations

11.

Imamura, Hideaki, Aya Shimizu, Hiroki Sato, et al.. (2001). Practical Synthesis of a 1.BETA.-Methylcarbapenem, J-111,225, Using 4-Mercapto-2-[4-(N-methylaminomethyl)phenyl] pyrrolidine as a Precursor.. Chemical and Pharmaceutical Bulletin. 49(4). 476–479. 1 indexed citations

12.

Imamura, Hideaki, Norikazu Ohtake, Aya Shimizu, et al.. (2000). Structure–activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compounds. Bioorganic & Medicinal Chemistry Letters. 10(2). 115–118. 6 indexed citations

13.

Imamura, Hideaki, Norikazu Ohtake, Aya Shimizu, et al.. (2000). Structure–activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems. Part 1: J-111,347 and related compounds. Bioorganic & Medicinal Chemistry Letters. 10(2). 109–113. 17 indexed citations

14.

Imamura, Hideaki, Norikazu Ohtake, Aya Shimizu, et al.. (2000). Discovery of novel trans -3,5-disubstituted pyrrolidinylthio-1β-methylcarbapenems. Bioorganic & Medicinal Chemistry. 8(8). 1969–1982. 6 indexed citations

15.

Imamura, Hideaki, Norikazu Ohtake, Shunji Sakuraba, et al.. (2000). Synthesis of J-111,347, a Novel 1.BETA.-Methylcarbapenem with Broad-spectrum Antibacterial Activity.. Chemical and Pharmaceutical Bulletin. 48(2). 310–311. 4 indexed citations

16.

Sugimoto, Yuichi, Hideaki Imamura, Aya Shimizu, et al.. (2000). Lipase-catalyzed kinetic resolution of ethyl 3-aryl-3-hydroxypropionate: preparation of the side chain of a novel carbapenem, J-114,870. Tetrahedron Asymmetry. 11(17). 3609–3617. 4 indexed citations

17.

Ohtake, Norikazu, Hideaki Imamura, Hideki Jona, et al.. (1998). Novel dithiocarbamate carbapenems with anti-MRSA activity. Bioorganic & Medicinal Chemistry. 6(7). 1089–1101. 18 indexed citations

18.

Ohtake, Norikazu, Hideaki Imamura, Hideki Jona, et al.. (1997). Novel dithiocarbamate carbapenems1 with anti-MRSA activity. Bioorganic & Medicinal Chemistry Letters. 7(13). 1617–1622. 9 indexed citations

19.

Imamura, Hideaki, et al.. (1959). Observations on the stereic distribution of Ascaris eggs in a rural village.. Kiseichūgaku zasshi. 8(4). 532–541. 1 indexed citations

20.

Ishidate, Motoi, et al.. (1953). [Studies on the toxicity of nitromin; interference of cystein upon nitromin toxicity].. PubMed. 44(2-3). 386–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact